Janssen Korea, Ltd., Korea clinical trials
Janssen Korea, Ltd., Korea is the lead sponsor of 3 current clinical trials in our South Korea register. 1 is recruiting patients now. All registered phases are Observational. The most-studied condition is Inflammatory Bowel Diseases.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Janssen Korea, Ltd., Korea
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
A Real-world Study in Participants With High-risk Non-Muscle-Invasive Bladder Cancer After Bacillus Calmette-Guérin Therapy in Korea
NCT07735793 · ClinicalTrials.gov ↗ · Urinary Bladder Neoplasms
|
Observational | Recruiting | 2026-10 | South Korea |
|
A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea
NCT07890285 · ClinicalTrials.gov ↗ · Pulmonary Arterial Hypertension
|
Observational | Not yet open | 2026-11 | South Korea |
|
A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea
NCT07520747 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases
|
Observational | Active, closed | 2026-04 | South Korea |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Janssen Korea, Ltd., Korea trials
3 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in South Korea | 3 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Inflammatory Bowel Diseases
Sponsors with the most current trials registered for this condition.
Questions about Janssen Korea, Ltd., Korea trials
How many clinical trials does Janssen Korea, Ltd., Korea sponsor?
Janssen Korea, Ltd., Korea is the lead sponsor of 3 current trials on ClinicalTrials.gov in our South Korea register, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Janssen Korea, Ltd., Korea trials recruiting?
Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.